Connection between proliferation rate and temozolomide sensitivity of primary glioblastoma cell culture and expression of YB-1 and LRP/MVP
- Авторы: Moiseeva N.1, Susova O.1, Mitrofanov A.1, Panteleev D.2, Pavlova G.2, Pustogarov N.2, Stavrovskaya A.1, Rybalkina E.1
-
Учреждения:
- Blokhin Russian Cancer Research Center
- Institute of Gene Biology
- Выпуск: Том 81, № 6 (2016)
- Страницы: 628-635
- Раздел: Article
- URL: https://journals.rcsi.science/0006-2979/article/view/150923
- DOI: https://doi.org/10.1134/S0006297916060109
- ID: 150923
Цитировать
Аннотация
Glioblastomas (GBL) are the most common and aggressive brain tumors. They are distinguished by high resistance to radiation and chemotherapy. To find novel approaches for GBL classification, we obtained 16 primary GBL cell cultures and tested them with real-time PCR for mRNA expression of several genes (YB-1, MGMT, MELK, MVP, MDR1, BCRP) involved in controlling cell proliferation and drug resistance. The primary GBL cultures differed in terms of proliferation rate, wherein a group of GBL cell cultures with low proliferation rate demonstrated higher resistance to temozolomide. We found that GBL primary cell cultures characterized by high proliferation rate and lower resistance to temozolomide expressed higher mRNA level of the YB-1 and MDR1 genes, whereas upregulated expression of MVP/LRP mRNA was a marker in the group of GBL with low proliferation rate and high resistance. A moderate correlation between expression of YB-1 and MELK as well as YB-1 and MDR1 was found. In the case of YB-1 and MGMT expression, no correlation was found. A significant negative correlation was revealed between mRNA expression of MVP/LRP and MELK, MDR1, and BCRP. No correlation in expression of YB-1 and MVP/LRP genes was observed. It seems that mRNA expression of YB-1 and MVP/LRP may serve as a marker for GBL cell cultures belonging to distinct groups, each of which is characterized by a unique pattern of gene activity.
Ключевые слова
Об авторах
N. Moiseeva
Blokhin Russian Cancer Research Center
Автор, ответственный за переписку.
Email: N.I.Moiseeva@gmail.com
Россия, Moscow, 115487
O. Susova
Blokhin Russian Cancer Research Center
Email: Kate_Rybalkina@mail.ru
Россия, Moscow, 115487
A. Mitrofanov
Blokhin Russian Cancer Research Center
Email: Kate_Rybalkina@mail.ru
Россия, Moscow, 115487
D. Panteleev
Institute of Gene Biology
Email: Kate_Rybalkina@mail.ru
Россия, Moscow, 119334
G. Pavlova
Institute of Gene Biology
Email: Kate_Rybalkina@mail.ru
Россия, Moscow, 119334
N. Pustogarov
Institute of Gene Biology
Email: Kate_Rybalkina@mail.ru
Россия, Moscow, 119334
A. Stavrovskaya
Blokhin Russian Cancer Research Center
Email: Kate_Rybalkina@mail.ru
Россия, Moscow, 115487
E. Rybalkina
Blokhin Russian Cancer Research Center
Автор, ответственный за переписку.
Email: Kate_Rybalkina@mail.ru
Россия, Moscow, 115487
![](/img/style/loading.gif)